SCHEMBL5169958

SCHEMBL5169958

Cc1nccc(C(N)=O)c1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT3 Q9NTG7 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
PIK3CB P42338 1/20 0.44
LIMK1 P53667 2/20 0.42
KDM4E B2RXH2 4/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KMT2A Q03164 1/20 0.42
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
NNMT P40261 2/20 0.41
P2RX7 Q99572 1/20 0.41
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
AHR P35869 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PARP1 P09874 2/20 0.38
NOS3 P29474 1/20 0.38
NOS2 P35228 1/20 0.38
CDC7 O00311 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5431919 0.84 KDM4E (0.55) TDP1KDM4EL3MBTL1KMT2AP2RX7
SCHEMBL30590435 0.84 SMN1; SMN2 (0.42) PIK3CBLIMK1KDM4EKMT2AMKNK1
SCHEMBL353138 0.82 SIRT3 (0.46) SIRT3TDP1PIK3CBLIMK1KDM4E
Hydrochloric Acid SCHEMBL5796678 0.80 SIRT3 (0.44) SIRT3TDP1PIK3CBLIMK1KDM4E
SCHEMBL9002808 0.80 SIRT3 (0.44) SIRT3TDP1PIK3CBKDM4EL3MBTL1
SCHEMBL38666595 0.79 KDM4E (0.53) KDM4EP2RX7MAPTALDH1A1
SCHEMBL17545204 0.79 KDM4E (0.53) KDM4EP2RX7MAPTALDH1A1
SCHEMBL21248760 0.79 NOS3 (0.45) SIRT3TDP1PIK3CBLIMK1KDM4E
SCHEMBL17195496 0.78 MKNK1 (0.44) SIRT3TDP1PIK3CBKDM4EL3MBTL1
SCHEMBL18426275 0.77 SIRT3 (0.50) SIRT3TDP1PIK3CBLIMK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021086879-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2021-05-06 WO disclosed
EP-1697308-A4 PHENYLAMIDE AND PYRIDYLAMIDE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER S DISEASE MERCK & CO INC (US) 2007-08-22 EP disclosed
EP-1697308-A2 PHENYLAMIDE AND PYRIDYLAMIDE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER S DISEASE Merck & Co., Inc. (US) 2006-09-06 EP disclosed
WO-2005065195-A2 PHENYLAMIDE AND PYRIDYLAMIDE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2005-07-21 WO disclosed